» Articles » PMID: 23478253

Generation of EX Vivo-vascularized Muscle Engineered Tissue (X-MET)

Overview
Journal Sci Rep
Specialty Science
Date 2013 Mar 13
PMID 23478253
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The object of this study was to develop an in vitro bioengineered three-dimensional vascularized skeletal muscle tissue, named eX-vivo Muscle Engineered Tissue (X-MET). This new tissue contains cells that exhibit the characteristics of differentiated myotubes, with organized contractile machinery, undifferentiated cells, and vascular cells capable of forming "vessel-like" networks. X-MET showed biomechanical properties comparable with that of adult skeletal muscles; thus it more closely mimics the cellular complexity typical of in vivo muscle tissue than myogenic cells cultured in standard monolayer conditions. Transplanted X-MET was able to mimic the activity of the excided EDL muscle, restoring the functionality of the damaged muscle. Our results suggest that X-MET is an ideal in vitro 3D muscle model that can be employed to repair muscle defects in vivo and to perform in vitro studies, limiting the use of live animals.

Citing Articles

Adipogenic-Myogenic Signaling in Engineered Human Muscle Grafts used to Treat Volumetric Muscle Loss.

Altamirano D, Mihaly E, Emmens J, Grayson W Adv Biol (Weinh). 2024; 8(12):e2400113.

PMID: 39294862 PMC: 11645239. DOI: 10.1002/adbi.202400113.


Generation of Bidimensional and Three-Dimensional Muscle Culture Systems.

Cosentino M, Musaro A Methods Mol Biol. 2024; 2835:229-247.

PMID: 39105919 DOI: 10.1007/978-1-0716-3995-5_19.


Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February - 2 March, 2024 (2024Pdm3).

Zampieri S, Bersch I, Smeriglio P, Barbieri E, Boncompagni S, Maccarone M Eur J Transl Myol. 2024; .

PMID: 38305708 PMC: 11017178. DOI: 10.4081/ejtm.2024.12346.


Modelling three-dimensional cancer-associated cachexia and therapy: The molecular basis and therapeutic potential of interleukin-6 transignalling blockade.

Cosentino M, Forcina L, Zouhair M, Apa L, Genovese D, Boccia C J Cachexia Sarcopenia Muscle. 2023; 14(6):2550-2568.

PMID: 37727078 PMC: 10751446. DOI: 10.1002/jcsm.13329.


Remodeled eX vivo muscle engineered tissue improves heart function after chronic myocardial ischemia.

Cosentino M, Nicoletti C, Valenti V, Schirone L, di Nonno F, Apa L Sci Rep. 2023; 13(1):10370.

PMID: 37365262 PMC: 10293177. DOI: 10.1038/s41598-023-37553-8.


References
1.
Grieshammer U, Sassoon D, Rosenthal N . A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages. Cell. 1992; 69(1):79-93. DOI: 10.1016/0092-8674(92)90120-2. View

2.
Shavlakadze T, Davies M, White J, Grounds M . Early regeneration of whole skeletal muscle grafts is unaffected by overexpression of IGF-1 in MLC/mIGF-1 transgenic mice. J Histochem Cytochem. 2004; 52(7):873-83. DOI: 10.1369/jhc.3A6177.2004. View

3.
Mauro A . Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961; 9:493-5. PMC: 2225012. DOI: 10.1083/jcb.9.2.493. View

4.
Lescaudron L, Creuzet S, Li Z, Paulin D . Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants. J Muscle Res Cell Motil. 1998; 18(6):631-41. DOI: 10.1023/a:1018679722112. View

5.
Zammit P, Golding J, Nagata Y, Hudon V, Partridge T, Beauchamp J . Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?. J Cell Biol. 2004; 166(3):347-57. PMC: 2172269. DOI: 10.1083/jcb.200312007. View